论文部分内容阅读
▲ ＦＤＡ6～ 7月份批准的药物新适应症Ｐｈａｒｍａｃｉａ公司的Ｇｅｎｏｔｒｏｐｉｎ(生长激素 ,ｓｏｍａｔｒｏｐｉｎ)的新适应症获ＦＤＡ批准用于患Ｐｒａｄｅｒ Ｗｉｌｌｉ综合征儿科患者生长障碍的治疗。这是美国批准用于这种适应症的第一个生长激素。此前 ,Ｇｅｎｏｔ
New Drug Approvals FDA approved in July-July Pharmacia’s new indication of genotropin (somatropin) has been approved by the FDA for the treatment of growth disorders in pediatric patients with Prader Willi Syndrome. This is the first growth hormone the United States has approved for this indication. Earlier, Genot